Henri Harland Resigns as President & CEO of Neptune, Acasti & NeuroBio

Henri Harland resigned as president and chief executive officer of Neptune Technologies & Bioressources Inc., Acasti Pharma Inc. and NeuroBioPharm Inc. Mr. Harland will remain a director of Neptune, Acasti and NeuroBio.
 
“I would like to thank Henri for his significant contributions as founder and executive of Neptune and its subsidiaries and wish him success in the future,” said Dr. Ronald Denis, chairman of Neptune.
 
The businesses will continue to be managed by a management and operations committee under the leadership of Neptune’s chief financial officer, Mr. André Godin. The search for a new president and chief executive officer is underway.